Next Steps In Car T-Cell Immunotherapies: Planning For Success With Continuous Improvement
- What does operations launch and readiness look like for Kite Pharma in 2018-19?
- Examining enhanced, ongoing collaboration with the FDA to align expectations
- Working with partners to develop new automation and manufacturing capability
- Steps to fully automate the process: What is established and what is still needed?
- Market expansion: Exploring the progress and trajectory of partnerships in Japan and China
- Focusing on the future: What’s next?